Acute Ischemic Stroke Interventional Study
NCT03803007
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Ischemic Stroke
Interventions
DRUG:
Intravenous ACT017 1000 mg
OTHER:
Intravenous Placebo
Sponsor
Acticor Biotech